Institute for International Research

Covance, with headquarters in Princeton, New Jersey, US, is one of the world's largest and most comprehensive drug development services companies, with annual revenues greater than $1.9 billion and more than 10,000 employees in over 60 countries. Covance has the people, process, client service, and global resources to respond to biotechnology and pharmaceutical clients’ toughest drug development challenges.

With the most comprehensive portfolio of preclinical, clinical development, and commercialization services, Covance provides industry-leading services, the world’s largest central laboratory network, and a global team of clinical trial and commercialization experts. 

The PAREXEL PACE (Peri-Approval Clinical Excellence) team has proven experience and rich expertise to meet the unique needs of all types of peri- and post-approval studies. Successful execution of these programs, in one or many countries, requires innovative approaches, in-depth regulatory knowledge, cost-effective solutions, established processes, and scalable approach.

UBC is a global medical and scientific affairs organization that partners with life science companies to develop and commercialize their products. We help clients generate authoritative, real-world evidence of product effectiveness, safety and value, to assist health care decisions and enhance patient care.

UBC brings together recognized scientific and industry experts, research operations professionals, and leading-edge technologies to provide innovative solutions across the product lifecycle.

With experts and operations in strategic locations worldwide, UBC offers the global reach and local expertise necessary to support the largest and most complex multinational product development programs. For more information, visit unitedbiosource.com.